QA: Rallybio Corp in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001739410_2025_Rallybio_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001739410, Rallybio Corp

  xvar xval
0 AssetsCurrent 67,841,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 115,000
3 remainder_Assets 152,000
4 LiabilitiesCurrent 6,242,000
5 LiabilitiesNoncurrent 212,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,625,000
9 ResearchAndDevelopmentExpense 41,507,000
10 remainder_Expenses 0
11 remainder_Revenues 600,000
12 remainder_NetIncome 2,721,000
13 remainder_ComprehensiveNetIncome 53,000
  yvar yval
0 Assets 68,108,000
1 Liabilities 6,454,000
2 Expenses 61,132,000
3 Revenues 600,000
4 StockholdersEquity 61,654,000
5 NetIncome -57,811,000
6 ComprehensiveNetIncome -57,784,500
7 BaseVar 69,534,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.06
9 EconomicCapitalRatio 3.06

Edgar->Model Mapping

Feature Distribution

Change over Time